BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0007 (55.74%)
Jul 27, 2026, 2:54 PM EST
BioAdaptives Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1.47 | -1.56 | -0.9 | -0.71 | -0.9 | -1.05 |
Depreciation & Amortization | 0.01 | 0 | 0 | 0.03 | 0.06 | 0.13 |
Other Amortization | 0.1 | 0.03 | 0.05 | 0.12 | 0.24 | 0.22 |
Asset Writedown & Restructuring Costs | - | - | 0.02 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 0 | 0 | 0 |
Stock-Based Compensation | - | - | - | - | - | 0.16 |
Provision & Write-off of Bad Debts | 0 | 0 | - | - | - | - |
Other Operating Activities | 0.71 | 0.89 | 0.42 | 0.32 | 0.18 | 0.14 |
Change in Accounts Receivable | -0 | -0 | - | - | - | - |
Change in Inventory | -0 | -0.03 | 0.06 | -0.01 | -0 | 0.01 |
Change in Accounts Payable | 0.06 | 0.05 | 0.04 | 0.04 | 0.18 | 0.23 |
Change in Other Net Operating Assets | 0.1 | 0.09 | 0.06 | -0.01 | 0 | -0 |
Operating Cash Flow | -0.5 | -0.52 | -0.25 | -0.22 | -0.23 | -0.16 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.02 | - | - | - | - |
Investing Cash Flow | -0.02 | -0.02 | - | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.26 | 0.03 | 0.05 | 0 | 0 |
Long-Term Debt Issued | - | - | - | 0.08 | 0.2 | 0.26 |
Total Debt Issued | 0.26 | 0.26 | 0.03 | 0.13 | 0.2 | 0.26 |
Short-Term Debt Repaid | - | - | - | -0.05 | -0.03 | -0.02 |
Total Debt Repaid | - | - | - | -0.05 | -0.03 | -0.02 |
Net Debt Issued (Repaid) | 0.26 | 0.26 | 0.03 | 0.08 | 0.17 | 0.24 |
Issuance of Common Stock | - | - | - | 0.18 | - | - |
Financing Cash Flow | 0.56 | 0.56 | 0.33 | 0.26 | 0.17 | 0.24 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.03 | 0.02 | 0.08 | 0.04 | -0.06 | 0.08 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.52 | -0.53 | -0.25 | -0.22 | -0.23 | -0.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2189.64% | -2921.68% | -1969.51% | -783.38% | -1323.12% | -802.24% |
Free Cash Flow Per Share | -0.05 | -0.05 | -0.03 | -0.04 | -0.32 | -0.70 |
Levered Free Cash Flow | -0.13 | 0.13 | -0.65 | 0.21 | 0.15 | -0.15 |
Unlevered Free Cash Flow | -0.13 | 0.14 | -0.65 | 0.19 | 0.09 | -0.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | 0 | 0.02 |
Change in Working Capital | 0.15 | 0.12 | 0.16 | 0.02 | 0.18 | 0.24 |